ANDA 75729, held by Abbvie. Famotidine.
As of Nov 15, 2026, ANDA 75729 (Famotidine Preservative Free In Plastic Container), held by Abbvie, was first approved by FDA on Dec 17, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 2001 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Famotidine Preservative Free In Plastic Container0.4MG/ML ยท injectable;injection | Famotidine | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
